You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscle Invasive or Metastatic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Tianjin (Cadonilimab)

Recruiting
  • Bladder Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 23, 2023

Muscle Invasive Bladder Carcinoma Trial (FL-101)

Withdrawn
  • Muscle Invasive Bladder Carcinoma
  • (no location specified)
Aug 17, 2022

Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Muscle-Invasive Bladder Carcinoma Trial in Roma (Nivolumab, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Roma, Italy
    Roberto iacovelli
Jan 10, 2022

Invasive Bladder Cancer Trial in Sutton (Pembrolizumab, Radiotherapy)

Recruiting
  • Invasive Bladder Cancer
  • Sutton, United Kingdom
    NIHR Biomedical Research Centre at RM and ICR (https://www.cance
Apr 16, 2021

Muscle-Invasive Bladder Carcinoma, Oligometastatic Disease Trial (metastasis directed therapy (MDT), Immunotherapy)

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Metastasis directed therapy (MDT)
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 3, 2022

Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • cisplatin based neoadjuvant chemotherapy
  • Radical cystectomy alone
  • Rome, Italy
    Riccardo Mastroianni
Mar 8, 2023

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Bladder Cancer, Metastatic Bladder Cancer, Urothelial Carcinoma Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Hartford, Connecticut
  • +10 more
Nov 23, 2022

Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

Not yet recruiting
  • Muscle Invasive Bladder Urothelial Carcinoma
  • Daily Adaptive External Beam Radiation Therapy
  • Saint Louis, Missouri
    Washington University, St. Louis
Jan 17, 2023

Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 11, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, AK104)

    Recruiting
    • Muscle Invasive Bladder Carcinoma
    • Beijing, China
      Cancer Institute and Hospital, Chinese Academy of Medical Scienc
    Oct 6, 2023

    Uromonitor asBiomarker for Optimization of NMIBC Management by

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
      • (no location specified)
      May 9, 2023

      Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

      Completed
      • Urinary Bladder Cancer
      • +4 more
      • Neutrophil to lymphocyte ratio
      • Cairo, Egypt
        Ain Shams university
      Jul 15, 2023

      Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

      Not yet recruiting
      • Non-Muscle- Invasive Bladder Cancer
      • Durvalumab
      • BCG
      • (no location specified)
      Jul 5, 2023

      Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

      Recruiting
      • Bladder Cancer
      • Pseudomonas aeruginosa
      • Jinan, Shandong, China
        Qilu hospital
      Jul 26, 2023

      Nivolumab in Japanese Muscle-invasive Urothelial Carcinoma

      Not yet recruiting
      • Muscle-invasive Urothelial Carcinoma
        • City, State, Japan
          Local Institution
        Mar 20, 2023

        Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • Cystoscopy
        • +2 more
        • (no location specified)
        Apr 4, 2023

        Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

        Recruiting
        • Non Muscle Invasive Bladder Cancer
        • N803 plus Bacillus Calmette-Guerin (BCG)
        • Honolulu, Hawaii
          Island Urology
        Aug 7, 2023

        Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

        Not yet recruiting
        • Non-Muscle Invasive Bladder Cancer
        • HER2
        • (no location specified)
        Jul 16, 2023

        Non-muscle Invasive Bladder Cancer Trial (TARA-002)

        Not yet recruiting
        • Non-muscle Invasive Bladder Cancer
        • TARA-002
        • (no location specified)
        Jul 14, 2023

        Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • BCG combined with Tislelizumab
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        Oct 12, 2022

        Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best

        Not yet recruiting
        • Muscle Invasive Bladder Carcinoma
        • +2 more
        • Best Practice
        • +6 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Sep 18, 2023